Skip to main content
OpenTrials
Not yet recruiting

NCT Number: NCT07819318

C-Raven LDCT: Lung Cancer Screening Intervention

This study is a three-arm, randomized controlled pilot of a lung cancer screening intervention. The investigators will recruit participants ages 50-80 who are likely to meet lung cancer screening guidelines. After eligibility screening, participants will be randomized to one of three educational interventions regarding lung cancer. Lung cancer screening outcomes will be assessed.

Not yet recruiting

Trial opening soon.

Get Notified

Key information

Age range

50 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Smoking is associated with a dramatically increased risk of lung cancer, with rates 10-40 times higher among those who smoke than among those who do not smoke, with smoking accounting for about 85-90% of all lung cancer cases. Screening for lung cancer with low-dose computed tomography (LDCT) has been shown to significantly reduce lung cancer mortality in high-risk populations. Lung cancer screening with annual LDCT is therefore recommended by the US Preventive Services Task Force (USPSTF) for all adults aged 50 to 80 years with a 20 pack-year history of smoking who currently smoke or have quit within the past 15 years. However, in a nationwide study of individuals eligible for lung cancer screening in 2022, only 18% were up-to-date with the recommended screening.

The investigators propose a three-arm, randomized controlled pilot of a lung cancer screening intervention. Recruitment will be carried out primarily through the electronic health record, with invitations sent to patients aged 50-80 who have a documented history of smoking but no chest CT on file within the past 18 months. The investigators will also partner with community organizations such as senior centers and churches to distribute information about the study.

Potential participants will be screened for eligibility for lung cancer screening. If eligible, the participants will undergo a consent process, complete baseline surveys (demographics, etc.), and be randomized to one of the following three study conditions:

  • Notification of eligibility for lung cancer screening with a recommendation to discuss with the participant's health care provider
  • Animated video on shared decision-making for LDCT with accompanying guide, offered as a downloadable PDF or mailed hard copy, per individual preference
  • Video and guide as in (b), plus a one-on-one call with a community health worker (CHW), 1-2 weeks after viewing the materials

Three months after receiving the intervention, follow-up surveys will be sent to assess attitudes toward and completion of lung cancer screening.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Existing record within the Johns Hopkins medical system
  • Age 50-80
  • Current tobacco use OR cessation within the past 15 years
  • 20-pack year history of smoking
  • No chest CT imaging within the past 18 months
  • English speaking
  • Willing to complete the study procedures, which include questionnaires and possibly a follow-up call

Exclusion criteria

  • Not meeting eligibility criteria

Treatment and study plan

Video/Brochure

Behavioral

Brief animated video that covers the basics of lung cancer screening and shows shared decision-making. An accompanying brochure uses images and information from the video to reinforce concepts (delivered via PDF or mail, per participant preference).

Video/Brochure/Follow-up Call

Behavioral

Brief animated video that covers the basics of lung cancer screening and shows shared decision-making. An accompanying brochure uses images and information from the video to reinforce concepts (delivered via PDF or mail, per participant preference). A follow-up call with a community outreach specialist/community health worker is made 1-2 weeks after the initial intervention to check in on participant plans regarding lung cancer screening and to assist with any barriers.

Primary outcomes

  1. Number of Participants with Completion of Lung Cancer Screening

    Time frame: 3 months

    Self-reported completion of low dose chest CT for lung cancer screening during the study follow-up period

Secondary outcomes

  1. Number of Participants with Clinician Discussion on Lung Cancer Screening

    Time frame: 3 months

    Self-reported conversation with clinician about lung cancer screening during the study follow-up period

  2. Number of Participants with Change in Intent to obtain lung cancer screening

    Time frame: 3 months

    Change in intent to obtain lung cancer screening

Study contacts

Contact information is provided by the study sponsor or research team.

Alejandra Ellison-Barnes, MD, MPH

CONTACT

[email protected]

410-955-5000

Heidi Hutton, PhD

CONTACT

[email protected]

443-287-2874

Sponsors and collaborators

Lead sponsor

Johns Hopkins University

Other

Collaborators

  • Maryland Cigarette Restitution Fund

Registry information

Official study title

C-Raven LDCT: Pilot Randomized Control Trial (RCT) of a Lung Cancer Screening Intervention

Acronym: C-Raven LDCT

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 14, 2026
Registry last updated
Sep 14, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.